SBI Securities’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$146 Sell
75
-150
-67% -$306 ﹤0.01% 3413
2026
Q1
$554 Buy
225
+130
+137% +$435 ﹤0.01% 2854
2025
Q4
$378 Buy
95
+90
+1,800% +$398 ﹤0.01% 2974
2025
Q3
$19 Sell
5
-300
-98% -$1.02K ﹤0.01% 3925
2025
Q2
$738 Sell
305
-600
-66% -$814 ﹤0.01% 2807
2025
Q1
$746 Hold
905
﹤0.01% 2709
2024
Q4
$769 Buy
+905
New +$1.01K ﹤0.01% 2727

Other funds holding NBP

SBI Securities's NBP Position: Q2 2026 in Review

SBI Securities reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 67% in Q2 2026, selling an estimated $306 and leaving 75 shares worth $146. The position accounts for ﹤0.01% of the portfolio, ranked #3413.

SBI Securities first reported a position in NBP in Q4 2024 and has held it in 7 quarters since. The position peaked at $769 in Q4 2024. 6 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • SBI Securities held 75 shares of NovaBridge Biosciences American Depositary Shares worth $146 as of Q2 2026.
  • SBI Securities sold 150 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $306.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3413 holding.
  • SBI Securities first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's NovaBridge Biosciences American Depositary Shares position peaked at $769 in Q4 2024.
  • 6 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.